Centessa Pharmaceuticals PLC - ADR

NAS:CNTA (UK)   ADR
$ 8.92 -0.01 (-0.11%) 10:08 PM EST
At Loss
P/B:
3.73
Market Cap:
$ 894.73M
Enterprise V:
$ 723.77M
Volume:
254.92K
Avg Vol (2M):
234.10K
Also Trade In:
Volume:
254.92K
At Loss
Avg Vol (2M):
234.10K

Business Description

Centessa Pharmaceuticals PLC

ISIN : US1523091007

Share Class Description:

CNTA: ADR
Description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 3.03
Equity-to-Asset 0.66
Debt-to-Equity 0.36
Debt-to-EBITDA -0.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.82
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -128.1
3-Year EPS without NRI Growth Rate -118.7
3-Year FCF Growth Rate -123.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 14.36
9-Day RSI 25.3
14-Day RSI 33.16
6-1 Month Momentum % 58.47
12-1 Month Momentum % 127.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8
Quick Ratio 8
Cash Ratio 6.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.8
Shareholder Yield % -1.45

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -2499.39
Net Margin % -2204.66
FCF Margin % -2342.2
ROE % -53.89
ROA % -38.18
ROIC % -326.22
ROC (Joel Greenblatt) % -1529.86
ROCE % -46.11